Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Cash from Operations: 2018-2024

Historic Cash from Operations for Milestone Pharmaceuticals (MIST) over the last 7 years, with Dec 2024 value amounting to -$28.8 million.

  • Milestone Pharmaceuticals' Cash from Operations fell 3.92% to -$12.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$52.5 million, marking a year-over-year decrease of 57.92%. This contributed to the annual value of -$28.8 million for FY2024, which is 37.86% up from last year.
  • Per Milestone Pharmaceuticals' latest filing, its Cash from Operations stood at -$28.8 million for FY2024, which was up 37.86% from -$46.4 million recorded in FY2023.
  • Milestone Pharmaceuticals' 5-year Cash from Operations high stood at -$28.8 million for FY2024, and its period low was -$52.5 million during FY2022.
  • Over the past 3 years, Milestone Pharmaceuticals' median Cash from Operations value was -$46.4 million (recorded in 2023), while the average stood at -$42.6 million.
  • Per our database at Business Quant, Milestone Pharmaceuticals' Cash from Operations slumped by 57.92% in 2022 and then surged by 37.86% in 2024.
  • Milestone Pharmaceuticals' Cash from Operations (Yearly) stood at -$50.7 million in 2020, then spiked by 34.51% to -$33.2 million in 2021, then slumped by 57.92% to -$52.5 million in 2022, then increased by 11.52% to -$46.4 million in 2023, then spiked by 37.86% to -$28.8 million in 2024.